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ABSTRACT 
Objectives: This epidemiology study examined risk factors uniquely associated with spasmodic 
dysphonia (SD).  
Study Design: Case-control. 
Methods: A questionnaire was administered to 150 patients with SD (with and without coexisting vocal 
tremor) and 136 patients with other structural, neurological, and functional voice disorders (excluding SD 
and vocal tremor). Questions included personal and family medical histories, environmental exposures, 
trauma, illnesses, voice use habits and the Short Form 36.   
Results: Several factors were uniquely associated with SD (α=0.05), including: (1) a personal history of 
cervical dystonia, sinus and throat illnesses, mumps, rubella, dust exposure and frequent volunteer voice 
use, (2) a family history of voice disorders, (3) an immediate family history of vocal tremor and 
meningitis, and (4) an extended family history of head and neck tremor, ocular disease, and meningitis. 
Vocal tremor coexisted with SD in 29% of cases. Measles and mumps vaccines were protective for SD. 
Conclusions: SD is likely multi-factorial, associated with several endogenous and exogenous factors. 
Certain viral exposures, voice use patterns, and familial neurological conditions may contribute to the 
onset of SD later in life. 
Key Words: spasmodic dysphonia, epidemiology, risk factors, voice disorders 
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INTRODUCTION 
 Spasmodic dysphonia (SD) is believed to be a focal dystonia of the larynx.
1-3
 Symptoms typically 
begin in the fifth decade of life and remain chronic thereafter.
4
 Features of SD are action-induced and 
task-dependent. 
5-8
 Adductor, abductor, as well as mixed types of SD, have been identified. Adductor SD 
involves spasms of the laryngeal adductor muscles, causing the vocal folds to over-close involuntarily 
during speech, creating a strained-strangled voice quality.
9
 Abductor SD produces involuntary opening of 
the vocal folds during speech, resulting in transient breathy phonatory breaks.
10
 Both adductor and 
abductor variants can adversely affect functional communication, leaving many permanently disabled by 
the condition. There are approximately 50,000 individuals with SD in the US alone, though the condition 
may be under-diagnosed.
11
 No cure exists for SD, with treatment options limited to BOTOX® 
chemodenervation, laryngeal nerve avulsion, or more recently, denervation-reinnervation surgical 
procedures.
12-14
 These treatments result in only partial remission of symptoms, and are less effective for 
the abductor variant. BOTOX® is temporary, necessitating regular travel to specialized voice clinics, and 
may be inaccessible to individuals living in more remote locations.
15
 To facilitate the development of 
more direct and effective treatments, the pathogenesis of SD must be elucidated. 
 Epidemiologic research has been established as a first-line approach to identify potential 
contributors to a particular disease or disorder. A National Institutes of Health-sponsored panel recently 
identified epidemiology as a top priority in SD research.
16
 Epidemiology is the study of the frequency, 
distribution, and causes of diseases in a population. Conventional epidemiologic research methods may be 
used to identify factors associated with a particular disease or disorder. A risk factor is a variable that is 
associated with a particular disease or disorder, occurring more frequently in the population with the 
disorder than in the general population. Although risk factors are correlational, and not necessarily causal, 
risk factors provide insight into the pathogenesis of the disease or disorder under study. Correlational 
epidemiologic research—sampling a broad range of potentially contributing variables—may be used as 
the basis for future studies that directly examine identified risk factors to determine disease pathogenesis. 
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be associated with SD. One small report
17
 described the onset of voice symptoms in 29 patients with SD. 
Results related to etiology were equivocal, with 15 individuals reporting SD onset following upper 
respiratory infection or head or neck trauma. Shortly thereafter, a study was reported involving interviews 
of 200 patients diagnosed with SD and a control group of 200 individuals with normal voices.
18
 The 
control group included a combination of patients from other ambulatory care clinics, individuals from the 
general population, and spouses of the patients with SD. The authors were conservative in their 
interpretation of medical, voice and social history data. However, they indicated that individuals with SD 
reported histories of more frequent viral and bacterial illnesses, greater frequency of hospitalizations, 
surgeries, trauma and injury, and a greater frequency of familial neurological conditions. Twenty percent 
of the patients with SD reported that their voice symptoms began either during or following an upper 
respiratory or throat condition. However, the authors did not find any significant associations between 
illness and SD onset. No associations with voice use patterns or occupations were observed. The authors 
concluded that SD was non-psychogenic and non-behavioral in origin. Although some patients in this 
study reported that the onset of SD occurred with stress, the authors did not find any significant 
association. This study was an important initial step toward clarifying the origin of SD, particularly by 
establishing the lack of association with potential psychogenic factors. However, the diverse control 
group and lack of conventional epidemiologic sampling procedures and statistical analyses make it 
difficult to establish risk factors associated with SD. Indeed, the authors strongly recommended caution 
during the interpretation of these initial findings. A later investigation examined the frequency of 
neurological disorder comorbidity in 110 individuals with SD.
1
 A database of individuals with primary or 
secondary dystonia was searched to identify those cases with laryngeal involvement. Case history, 
fiberoptic laryngoscopy, audio-recording, laryngeal electromyography, and neurological evaluation data 
were collected. Of the 110 SD cases, 66% also had coexisting primary dystonia and 34% had coexisting 
secondary dystonia. Of the primary dystonia subgroup, 31% had focal dystonia, 25% had segmental 
cranial dystonia, 46% with dystonia in all segments, and 23% had generalized dystonia; and, familial 
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was identified in 62% of cases. Electromyography data indicated regular and irregular vocal tremor in 6% 
and 23% of cases, respectively. In 19% of cases, SD onset was later followed by the presence of 
additional dystonia symptoms. The authors stressed that SD is a focal dystonia that often coexists with or 
presents with a family history of other neurological conditions, and that individuals with SD should 
receive counseling and appropriate treatment related to dystonia comorbidity. Clearly the sampling 
method employed in this investigation (i.e., cases taken from a cohort of individuals already diagnosed 
with some other form of dystonia) limits the interpretation of prevalence data related to familial and 
comorbid neurological symptoms. However, the study provides additional evidence for the possible 
association of both endogenous and exogenous factors with SD. 
 More recently, a fairly large-scale investigation was undertaken involving 168 individuals with 
SD and a first-degree-relative control group.
19
 Individuals in the control group were reported to have 
similar environmental and geographical histories to the SD group. SD diagnosis was confirmed by a 
multi-disciplinary team including a physician and speech-language pathologist using criteria previously 
reported in the literature.
20,21
 Detailed case histories including medical and family histories, illnesses, 
environmental exposures, symptom onset, the Voice Handicap Index and the Short Form (SF) 36 were 
collected. SD participants were identified during routine BOTOX® injection clinic visits. A greater 
frequency of writer’s cramp (11% versus 2%) and essential tremor (26% versus 4%) was observed for the 
SD group as compared to the control group. For the SD group, 65% had a history of either mumps or 
measles. Factors that were present at the time of onset included upper respiratory infection (30% of cases) 
and major life stress (21% of cases). No other familial or environmental factors were uniquely associated 
with the SD group. Of note, the SD patients also demonstrated statistically significant improvements in 
Voice Handicap Index scores and social functioning and mental health subtests of the SF-36 after 
treatment with BOTOX®. This investigation offers further support particularly for the role of 
exogenous/environmental exposures as possible causes or triggers for SD. The lack of significant 
neurological or family history findings might be explained by the selection of first-degree relatives as a 
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in part, for the absence of findings related to potentially inherited neurological predispositions that might 
have existed in both groups. These limitations notwithstanding, this study provides motivation for 
additional case-control epidemiologic studies to isolate risk factors specific to SD. In the first large case-
control study employing conventional epidemiologic methodology, our group investigated potential 
endogenous and exogenous factors in 150 SD cases and 150 medical controls using a previously-vetted 
questionnaire,
6,7; 22,23
 modified to include variables potentially associated with SD.
24
 The questionnaire 
was employed to acquire detailed personal and family medical histories, including an exhaustive list of 
neurological conditions and symptoms, as well as illnesses, exposures, traumas, and voice use practices. 
Conventional epidemiologic methods, including sampling procedures and statistical analyses, were used 
to identify risk factors uniquely associated with SD, as compared with medical-treatment-seeking case 
controls. Identified risk factors for SD included 1) a personal history of mumps, blepharospasm, tremor, 
intense occupational and avocational voice use, and a family history of voice disorders; 2) an immediate 
family history of meningitis, tremor, tics, cancer and compulsive behaviors; and 3) an extended family 
history of tremor and cancer. Protective factors included the hepatitis vaccine, with greater a frequency of 
several immunizations reported by the medical control group as compared to the SD group. The results 
indicated that a combination of inherited and environmental factors might influence SD etiology. 
Although this study represented an important step in SD epidemiologic research, it did not account for 
differences that might exist between risk factors associated with voice disorders in general, and those 
associated specifically with SD. Therefore it is essential to study risk factors for SD within the context of 
other voice disorders. To that end, the present investigation was undertaken to identify potential inherited 
and environmental risk factors uniquely associated with SD as opposed to the general classification of 
voice disorders.  
MATERIALS AND METHODS 
Participant Identification and Recruitment 
One hundred and fifty (150) patients with SD and 136 patients with other structural, neurological, 
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Disorders Center participated in the study (Internal Review Board approval 00025341). Potential 
participants with SD were identified and recruited in two ways. First, consecutive patients with SD were 
approached during routine clinic appointments, including initial evaluations, follow-up visits, and 
laryngeal BOTOX
®
 injection appointments. Second, patients previously seen at our center received a 
letter and were subsequently telephoned and invited to participate. Of the 192 patients approached and 
invited to participate, 150 individuals with SD completed the study. Participants recruited for the voice 
disorders case-control (VC) group included consecutive patients seen during routine clinical 
appointments, such as initial evaluations, follow-up visits, and voice therapy appointments. Voice 
disorder control group diagnoses are included in Table I. Of the 160 patients approached and invited to 
participate, 136 VC individuals completed the study. 
 Voice disorder diagnosis was confirmed by a multi-disciplinary team of professionals including a 
laryngologist and one of four speech-language pathologists. Diagnosis was assigned following a thorough 
evaluation including a detailed case history, auditory-perceptual evaluation, and 
videolaryngostroboscopy, employing diagnostic criteria previously established and reported.
25-28
 
Individuals were excluded from the study if they were symptomatic for moderate or severe hearing loss. 
Other exclusion criteria included diagnosed cognitive impairments.  
Data Collection 
 The survey instrument used in this investigation was a previously-validated questionnaire 
developed for individuals with voice disorders, with additional modifications specific to SD.
 6,7; 22,23
  
Questions included personal and family medical histories—including a detailed neurological history— as 
well as a history of environmental exposures, trauma, illnesses, voice use habits and the Short Form (SF) 
36.  The SF-36 is a psychometrically validated general health questionnaire designed to sample physical, 
psychological, and emotional health and well-being. The SF-36 has been used to determine the relative 
burden of diseases among different populations. In this study, the SF-36 was administered to determine if 
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Trained examiners administered the questionnaire to each participant and were periodically audited to 
ensure accuracy. The questionnaire required approximately one hour to administer.  
Statistical Analysis 
All data were examined using frequencies, proportions, means and standard deviations. The chi-
square test for independence was used to determine statistical significance from cross-tabulation bivariate 
analyses between the SD and VC groups. Odds ratios (OR) were obtained using logistic regression, 
adjusted for potential confounding factors such as age, sex, and income level. The OR is a commonly 
used measure of the probability of exposure among the cases relative to the probability of exposure 
among the controls. An OR = 1 indicates the exposure does not have an effect on the probability of the 
disease. On the other hand, if the OR > 1 the exposure increases the probability of the disease, whereas if 
the OR < 1 then the exposure decreases the probability of the disease. Ninety-five percent confidence 
intervals were obtained for the estimated ORs. Confidence intervals that do not overlap 1.0 indicate 
statistical significance at a 0.05 alpha level. Analyses were performed using SAS version 9.2 (SAS 
Institute Inc., Cary, NC, USA, 2007).  
RESULTS 
Demographics 
Participants ages ranged from 20.4 to 92.5 years (M = 59.7, SD = 14.6) and did not significantly 
differ between SD and VC participants (t = 1.60, P = 0.112). Years of education ranged from 8 to 23 
(Mean = 15.3, SD = 2.5) and did not significantly differ between SD and VC participants (t = - 0.54, P = 
0.592). Demographic data for SD and VC groups are presented in Table I. Participants ages 60 to 69 and 
white (non-Hispanic) were significantly more likely to be in the SD group.  
Short Form (SF) 36 
 Scores from the SF-36 were compared for the SD versus VC groups. Multivariate analysis of 
variance showed that the combination of the eight SF-36 subscales regressed on group was significant 
(Wilks’ Lamda P < 0.001).  The scales were transformed to 0-100 and scored so that higher scores 
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functioning (M = 85.3 for SD and 75.1 for Control; F = 11.2, P < 0.001; Norm = 84.2), role limitations 
due to physical health (M = 77.7 for SD and 53.7 for Control; F = 27.9, P < 0.001; Norm = 80.9), 
energy/fatigue (M = 58.4 for SD and 51.9 for Control; F = 6.0, P = 0.015; Norm = 60.9), social 
functioning (M = 86.4 for SD and 75.0 for Control; F = 14.5, P < 0.001; Norm = 83.3), pain levels (M = 
78.4 for SD and 68.4 for Control; F = 13.1, P < 0.001; Norm = 75.2), and general health (M = 71.8 for SD 
and 63.3 for Control; F = 10.4, P = 0.001; Norm = 71.9). Role limitations due to emotional stresses (M = 
88.4 for SD and 85.5 for Control; F = 0.77, P = 0.380; Norm = 81.3) and emotional well-being (M = 79.7 
for SD and 79.6 for Control; F = 0.0, P = 0.963; Norm = 74.7) were not significantly associated with 
group. 
Endogenous Risk Factors 
 Differences between the SD and VC groups based on select medical history variables are 
presented in Tables II-IV. Factors were included in each table if differences were observed between the 
groups based on that variable (α = 0.10). Statistically significant ORs (α = 0.05) are indicated in bold. 
Sampled endogenous factors consisted of an extensive list of neurological diseases and symptoms—
including dystonias and tremor variants—as well as central nervous, metabolic, autoimmune and immune 
system diseases, respiratory conditions, health or medical conditions, personality traits and psychological 
conditions. For purpose of this study, questions were classified as pertaining to the individual’s personal 
history (PH), immediate family history (IFH)—including included parents, brothers, sisters and 
children—and extended family history (EFH), including grandparents, grandchildren, aunts, uncles and 
cousins.  
Significant PH factors unique to the SD group are presented in Table II. A statistically significant 
difference based on a PH of cervical dystonia, with a greater frequency in the SD group, was observed (α 
= 0.05). A family history of voice disorders was also significantly associated with SD (17% for SD versus 
7% for VC, P<0.001; OR = 2.7, 95% CI = 1.2-6.1 after adjusting for age, gender, and race). Twenty-nine 
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Among the SD group, those with head/neck tremor or voice/vocal tremor were significantly more 
likely to have cervical dystonia (14.3% vs. 4.0%, Chi-square[1] = 5.18, P = 0.023). A marginally 
insignificant relationship was observed between head/neck tremor or voice/vocal tremor and cancer 
(22.4% vs. 10.9%, Chi-square[1] = 3.52, P = 0.061). There were no other significant relationships 
involving head/neck tremor or voice/vocal tremor and the previous medical conditions listed in Table II. 
Significant IFH factors unique to the SD group are presented in Table III. OR analyses indicated 
significantly greater associations with the SD group versus the VC group if they had an IFH of vocal 
tremor, meningitis and acid reflux (α = 0.05). Significant EFH factors unique to the SD group are 
presented in Table IV. OR analyses indicated significantly greater associations with the SD group versus 
the VC group if the had an EFH of head or neck tremor, ocular disease and meningitis (α = 0.05). Among 
the SD group, there were no other significant relationships involving head/neck tremor or voice/vocal 
tremor and the previous medical conditions listed in Tables III and IV. 
Exogenous/Environmental Risk Factors 
Differences between the SD and VC groups based on select health symptoms, illnesses, voice use 
patterns, traumas and environmental exposures are presented in Tables V and VI. Factors were included 
in each table if differences were observed between the groups based on that variable (α = 0.10). 
Statistically significant ORs (α = 0.05) are indicated in bold. Exogenous factors sampled included 
surgeries, traumas/injuries, chemical exposures, viral infections, vaccinations, alcohol/tobacco/drug use, 
musculoskeletal tension, and voice use patterns. OR analyses indicated that individuals were significantly 
more likely to be in the SD group versus the VC group if they had a greater frequency of sore throats, 
rubella, and avocational voice use (α = 0.05). A statistically significant difference based on a history of 
having contracted mumps and having extensive dust exposure, with a greater frequency in the SD group, 
was also observed (α = 0.05). Although a high level of both SD and VC groups indicated having ever 
been employed in a job that required extensive voice use on a daily basis, those in the SD group had been 
employed in this type of job more years (84.6% for 10 or more years versus 62.4% for 10 or more years, 
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Among the SD group, we also considered the relationship between those with head/neck tremor 
or voice/vocal tremor and the variables in Tables V and VI. Those with head/neck tremor or voice/vocal 
tremor were significantly more likely to have sinus infection at least once per year (46.9% vs. 26.7%, 
Chi-square[2] = 6.12, P = 0.047). Individuals with head/neck tremor or voice/vocal tremor were also 
significantly more likely to have had measles (87.0% vs. 69.5%, Chi-square[1] = 5.08, P = 0.024).  
Protective Factors 
Several factors were observed to have significantly greater frequency in the VC group versus the 
SD group. OR analyses indicated significantly greater associations with the VC group for the following 
factors: 1) a PH of acid reflux, asthma, cancer, neurological symptoms, mood disorders, colds, past choral 
singing, head trauma with loss of consciousness, measles vaccine, mumps vaccine, head or neck surgery, 
and trunk or thorax surgery and 2) an EFH of social anxiety and being overly emotional. 
DISCUSSION 
 This case-control epidemiologic investigation compared a group of individuals with SD (with and 
without coexisting vocal tremor) to a group of individuals with other structural, functional or neurological 
voice disorders. The purpose of the study was to identify endogenous and exogenous risk factors unique 
to SD. This investigation was the first to examine potential causes of SD within the context of other voice 
disorders, which is critical to ensure that identified factors are specific to SD and are not merely 
associated with voice problems in general (i.e., to determine specificity versus commonality). 
Conventional epidemiologic measures, including odds ratio analyses, were employed to isolate risk 
factors uniquely associated with SD. Several risk factors related to neurological factors, voice use 
practices, and viral exposures were identified. Protective factors were also identified. A discussion of 
each of the salient findings from this investigation is provided below. 
Neurological Risk Factors 
 A PH of cervical dystonia, as well as a PH and familial history of tremor was significantly 
associated with the SD group. Individuals with SD plus coexisting tremor were more likely to have 
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have cervical dystonia than the VC group. This finding is not surprising given the previously reported 
comorbidity of SD, vocal tremor, and other neurological conditions in the literature. In our group of 
patients with SD, 29% had coexisting vocal tremor. This finding is consistent with previous reports that 
approximately one-third of individuals with SD also experience vocal tremor.
1; 18,19
 Essential tremor is a 
risk factor for other forms of adult-onset dystonia,
29,30
 and the frequent coexistence of SD and tremor may 
reflect a neurological vulnerability or predisposition to the development of movement disorders in this 
population. The coexistence of cervical dystonia in a subset of individuals in the SD group would support 
this theory, and is also consistent with earlier research documenting the likelihood of more than one 
regional or segmental dystonia in patients with SD.
1 
A recent investigation of 128 individuals with SD 
and 146 voice disorder controls offered further evidence for the frequent co-occurrence of SD and 
tremor.
31
 Vocal tremor was present in 26% of cases, and non-vocal tremor in 21% of cases. The authors 
stressed the need for referral to neurology to evaluate such patients for other potentially comorbid 
neurological conditions. Furthermore, distinguishing essential voice tremor from SD can be difficult, 
especially as the amplitude of the tremor becomes sufficient to create phonatory breaks in connected 
speech. This has led to a clinical classification system which includes SD only, SD “with” voice tremor, 
and SD “of” essential voice tremor. Therefore, studies involving coexisting SD and tremor should 
consider the problem of potential overlap among SD and vocal tremor variants. It is possible that the 
comorbidity of SD and tremor may be overestimated due to diagnostic imprecision and overlapping 
auditory-perceptual features. Laryngeal electromyography, careful auditory-perceptual evaluation, and 
BOTOX® treatment response may be valuable tools in differential diagnosis. 
Individuals with SD were more likely to report a family history of voice disorders. This 
potentially may reflect the heritability of voice tremor, as almost one-third of our SD cases had coexisting 
voice tremor. The family history of voice disorders association is also noteworthy when considering the 
diagnoses included in the VC group, several of which are believed to have familial or shared 
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Regardless, findings from this investigation indicate that individuals with SD have a greater frequency of 
cervical dystonia as well as a family history of tremor, and provide additional support for a genetic-
transmission model of SD.  
Viral Exposures 
A PH of upper respiratory infections involving sinus or sore throat symptoms, mumps, rubella, 
and a family history of meningitis were associated with the SD group with greater frequency than the VC 
group. Individuals who reported an IFH of meningitis were more likely to be in the SD group, and to have 
a history EFH of meningitis. Experiencing sore throats more than once per year was associated with the 
SD, as was the presence of sinus infections one or two times per year. The SD group also reported a 
greater frequency of mumps and rubella than the VC group, 67% versus 51% and 14% versus 7%, 
respectively. While individuals in the SD group were more likely to have contracted mumps and rubella, 
individuals with SD plus coexisting tremor subset were also more likely to have contracted measles 
(87.0% versus 69.5%). Vaccinations for these diseases were protective against SD. In general, these 
findings are consistent with SD versus medical control comparisons demonstrating the increased 
frequency of viral exposures in patients with SD.
24
 
 Viral exposure has been linked to numerous diseases and conditions, including multiple sclerosis, 
chronic fatigue syndrome, and cancer. Viruses can affect the central or peripheral nervous systems, or 
both, and can result in neuropathy. For example, viral-induced unilateral vocal fold paralysis and 
subsequent synkinesis has been described.
32
 Mumps is a viral infection that affects the parotid glands that 
can cause encephalitis—or brain inflammation—and meningitis. Rubella affects the lymph nodes and 
joints, and can also cause encephalitis, as well as inflammation of the nerves and testicles. Meningitis 
creates swelling of the leptomeninges and subarachnoid cerebrospinal fluid, affecting the central nervous 
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potential for creating subtle changes in the brain that might predispose an individual to developing a focal 
laryngeal dystonia, such as SD, later in life is unknown.  
 Changes in the brain associated with the speech control circuits have been identified in patients 
with SD. Abnormalities in the white matter in the laryngeal motor control circuit, involving the internal 
capsule and the cerebellum, as well as additional changes in the thalamus, corticobulbar tract, and the 
basal ganglia have been identified in patients with SD.
3
 Structural and functional abnormalities involving 
gray matter have been demonstrated in the laryngeal primary sensorimotor cortex, the inferior frontal 
gyrus, the superior/middle temporal and supramarginal gyri, and the cerebellum. Together, these findings 
indicate complex changes in the brain involving regions of motor execution, motor preparation, and 
possibly auditory processing regions that are active during speech production.
33
 Simonyan and 
colleagues
3
 have suggested that a slow progressive neurodegenerative or metabolic process might be 
responsive for or contribute to the pathophysiology of SD. We hypothesize that viral exposures might 
contribute to the neurodegenerative changes observed in these imaging studies. Viral exposures 
associated with encephalitis seem to be particularly associated with SD pathogenesis.  
Voice Use Factors 
A history of frequent, occupationally intense voice use was prevalent in both the SD and VC 
groups (82.7% and 80.2%, respectively). The majority of individuals in the SD and VC groups indicated 
that they had been employed in a job that required extensive voice use on a daily basis. However, those in 
the SD group had been employed in this type of job for more years (e.g., 84.6% for 10 or more years 
versus 62.4% for 10 or more years). This finding is consistent with previous SD versus vocally normal 
control comparisons. Related to avocational voice use, 59% of individuals in the SD group reported a 
greater frequency of voice demands during volunteer activities, versus 41% of the VC group. Although a 
history of intense voice use is prevalent in many voice disorders (e.g. vocal nodules, polyps etc.), this 
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patients with muscle tension dysphonia, unilateral vocal fold paralysis, and presbylaryngis within the VC 
group, whose etiologies are not necessarily tied to vocal overuse, may have contributed to this finding. 
Yet, this is the second study that has identified intense voice use as a risk factor in SD development.
24
  
In this regard, repetitive fine motor movements have been linked to the development of focal 
dystonias.
34
 Instrumentalists may experience musicians’ dystonia, a task-specific movement disorder of 
the affected body locus, such as the hands or oral musculature.
35
 Several risk factors for musicians’ 
dystonia have been identified, including a family history of the disease, pain—possibly due to trauma, 
nerve entrapment or overuse—as well as anxiety, which has been theorized to engrain aberrant motor 
memory.
36-44 
Treatment often includes BOTOX® injections, medications such as Trihexyphenidyl, and 
therapy to modify ergonomics and movement form related to use of the instrument. Perhaps the increased 
frequency of occupational and avocational voice use in the SD population might be analogous to 
musicians’ dystonia, whereby the repeated muscular movements involved in the onset and offset of 
voicing might contribute to a focal dystonia of the larynx. Although it is unlikely that voice use habits 
alone might account for the development of SD, perhaps voice use demands and practices might influence 
or localize laryngeal dystonia in individuals who are genetically predisposed, or who have experienced 
other potentially contributing diseases or exposures.  
Additional Considerations 
 The SF-36 was administered to establish general health parameters for the SD and VC groups. 
Psychometrically-validated general health assessments are particularly useful when attempting to identify 
risks for a particular disease group as compared with a control group, so that any observed associations 
simply related to disease severity are not erroneously attributed to risk factors. In this study, if the VC 
group had higher (better) scores than the SD group, it would be critical to distinguish those factors 
associated with SD selection and those associated with SD disease severity. Interestingly, in the present 
study, SF-36 scores were lower (worse) for the VC group on the following subtests: physical functioning, 
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There are a few possible explanations for this difference. Indeed, perhaps the VC group simply 
experienced inferior overall health than the SD group. Although other demographic variables such as age, 
income level, and race were not significantly different between the two groups, differences in overall 
physical health are possible. It is also possible, however, that the group differences might be explained by 
the VC group perhaps exaggerating the number or severity of symptoms (i.e., somatizing symptoms) 
related to physical health. The largest diagnostic category in the VC group was muscle tension dysphonia 
(36%), and increased symptom-reporting (and somatization) has been observed in this patient 
population.
45,46
 However, it should be noted that the emotional health subtests, including role limitations 
due to emotional stresses and emotional well-being, were not significantly different between groups. 
Thus, it is important to emphasize that the risk factors that were more prevalent in the SD group versus 
the VC group were not merely related to differences in general health. 
 It is also worth mentioning that several factors were more prevalent in the VC group as compared 
with the SD group, including: 1) a PH of acid reflux, asthma, cancer, neurological symptoms, mood 
disorders, colds, past choral singing, head trauma with loss of consciousness, measles vaccine, mumps 
vaccine, head or neck surgery, and trunk or thorax surgery and 2) an EFH of social anxiety and being 
overly emotional. The measles and mumps vaccines are likely a protective factor for SD, suggesting that 
receiving the vaccine diminishes the likelihood of contracting the virus, which has been associated with 
SD pathogenesis. Other factors, such as those associated with reflux, psychological factors, and other 
somatic complaints may be associated with certain VC diagnoses as discussed previously. However, from 
the results it seems that vaccination against measles and mumps affords some protective value by 
reducing the risk for SD development. 
 It should also be acknowledged that the present investigation represents an initial step toward 
understanding SD etiology. Error associated with self-report data is a known issue. Future studies 
involving SD families, including blinded neurological evaluations and voice assessment measures, will be 
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CONCLUSION 
 SD is likely multi-factorial. Familial risk factors and environmental exposures have been linked 
to SD. These findings are consistent with current genetic and brain imaging studies that elucidate the 
pathogenesis and pathophysiology of SD. Future research—modeling associations among inherited risks 
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TABLE I: Frequency Distributions of the Spasmodic Dysphonia and Voice Disorders Control 
Groups According to Selected Diagnostic and Demographic Variables 
 







 No. % No. % P value   
Diagnosis 
Adductor spasmodic dysphonia 
Abductor spasmodic dysphonia 
Mixed spasmodic dysphonia 
Muscle tension dysphonia 
Presbylaryngis 



















































































































































































   Male 























   23-49 
   50-59 
   60-69 



































   White, non-Hispanic 























   12 
   13-15 
   16-17 



































Gross Annual Income 
   < $20,000 
   $20,000 - $39,999 
   $40,000 – $59,999 
   ≥ $60,000 















































Bolded odds ratios statistically significant, P < 0.05. 
†
Adjusted for age, gender, and race/ethnicity. 
 
TABLE II: Frequency Distributions of the Spasmodic Dysphonia and Voice Disorders Control 
Groups According to Personal History Factors 
 







 No. % No. % P value   
Cervical Dystonia  
   No 






















   No 






















   No 






















   No 






















   No 






















   No 






















   No 





































   Yes 12 8 22 16 0.4 0.2-0.8 
Mood Disorders 
   No 






















   No 





















Bolded odds ratios statistically significant, P < 0.05. 
†
Adjusted for age, gender, and race/ethnicity. 
 
 
 TABLE III: Frequency Distributions of the Spasmodic Dysphonia and Voice Disorders Control 
Groups According to Immediate Family History Factors 
 







 No. % No. % P value   
Vocal Tremor 
   No 






















   No 




















   No 





















Ocular (eye) disease 
   No 






















   No 





















Bolded odds ratios statistically significant, P < 0.05. 
†
Adjusted for age, gender, and race/ethnicity. 
 
 TABLE IV. Frequency Distributions of the Spasmodic Dysphonia and Voice Disorders Control 
Groups According to Extended Family History Factors 
 







 No. % No. % P value   
Head/neck tremor 
   No 






















   No 





















Ocular (eye) disease 
   No 






















   No 























   No 




























Distrust of others 
   No 






















   No 





















Overly emotional        
   No 













Bolded odds ratios statistically significant, P < 0.05. 
†









 TABLE V. Frequency Distributions of the Spasmodic Dysphonia and Voice Disorders Control 
Groups According to Selected Health Symptoms and Voice Use Patterns 
 







 No. % No. % P value   
Colds 
   < 1 per year 
   1-2 per year 




























   < 1 per year 
   1-2 per year 




























   < 1 per year 
   1-2 per year 



























Post nasal drip 
   Chronic 
   Seasonal 
   Occasional 

































Choral singing – past 
   No 





















Voice use during other 
volunteer activities –past 



























        
Bolded odds ratios statistically significant, P < 0.05. 
†
Adjusted for age, gender, and race/ethnicity. 
 
 TABLE VI. Frequency Distributions of the Spasmodic Dysphonia and Voice Disorders Control 
Groups According to Selected Illnesses, Environmental Exposures and Traumas 
 









 No. % No. % P value   
Chemical Exposure        
   No 
   Yes 



















Head Trauma with loss of 
consciousness 
   No 
   Yes 



































   No 






















   No 
   Yes 




























   No 
   Yes 











































   Yes 













Vaccine - Measles 
   No 
   Yes 



























Vaccine - Mumps 
   No 
   Yes 



























Vaccine - Rubella 
   No 
   Yes 



























Vaccine – Swine flu 
   No 
   Yes 



























Dust – Past exposure 
   No 





















Fumes from cleaning 
products – Past exposure 
   No 




























Surgery – Head/neck 
   No 





















Surgery – Chest/thorax 
   No 





















Bolded odds ratios statistically significant, P < 0.05. 
†
Adjusted for age, gender, and race/ethnicity. 
 
 
 
 
